This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Taheebo Japan Co., Ltd.. Active years: 2009-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2014
Title: Mitsuaki Yamashita: Innovator in Anticancer Compounds
Introduction
Mitsuaki Yamashita is a notable inventor based in Takasaki, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer compounds. With a total of 2 patents to his name, Yamashita's work is recognized for its innovative approaches to drug preparation.
Latest Patents
Yamashita's latest patents include two groundbreaking inventions. The first patent focuses on the "Preparation of anticancer-active tricyclic compounds via alkyne coupling reaction." This invention provides a novel method for synthesizing tricyclic compounds that exhibit anticancer properties. The second patent is titled "Preparation of Optically active 2-(1-hydroxyethyl)-5-hydroxynaphtho[2,3-b]furan-4,9-diones having anticancer activities." This method allows for the efficient preparation of a specific compound that is useful as a medicine, utilizing an asymmetric ruthenium complex and a hydrogen donor to achieve high efficiency and low production costs.
Career Highlights
Yamashita is currently associated with Taheebo Japan Co., Ltd., where he continues to advance his research in medicinal chemistry. His work has garnered attention for its potential impact on cancer treatment, showcasing his dedication to improving healthcare through innovative solutions.
Collaborations
Yamashita collaborates with esteemed colleagues, including Akira Iida and Harukuni Tokuda. Their combined expertise contributes to the success of their research endeavors and the development of new therapeutic compounds.
Conclusion
Mitsuaki Yamashita stands out as a prominent inventor in the field of anticancer research. His innovative patents and collaborative efforts highlight his commitment to advancing medical science. Through his work, he continues to pave the way for new treatments that could benefit countless patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile